New! Sign up for our free email newsletter.
Science News
from research organizations

Cancer tumors form surprising connections with healthy brain cells

Date:
September 27, 2019
Source:
The University of Bergen
Summary:
Anti-epileptic medicine can curb the dangerous communication and possibly be part of future treatment.
Share:
FULL STORY

In a collaborative study by the University of Bergen, Universität Heidelberg and Das Deutsche Krebsforschungszentrum in Germany, researchers discovered that cancer cells in the brain communicate with healthy brain cells in a different way than previously assumed.

"We were surprised to learn that neurons form synapses with cancer cells, which we thought only healthy cells do," says Professor Hrvoje Miletic of the Department of Biomedicine at the University of Bergen (UiB).

Disturbing signals

The job of synapses is to transmit signals between the cells, which tell them what to do. Previously, researchers have assumed that only healthy cells form such synapses to communicate with each other.

Researchers have known that cancer cells communicate with healthy neurons, but not how. Thanks to the neuroscience expertise at Heidelberg University and brain cancer models from UiB, researchers could see how neurons form synaptic connections with cancer cells, stimulating cancer growth.

"The new insight has allowed us to open a completely new field to understand malignant brain cancer and how to attack it. Controlled testing of anti-epileptic medicine is perhaps a possible new strategy," Miletic says.

Anti-epileptic medicine against brain cancer

In epilepsy, neurons overreact, transmitting a slew of uncontrolled electrical impulses. The new research shows that impulses from neurons are transmitted to cancer cells through synapses and transformed into signals in cancer cells that stimulate growth.

Brain tumour patients often have epilepsy and are periodically put on anti-epileptic medications, but quit taking them after the seizures stop. Consequently, a future controlled study of anti-epileptic drugs could show whether there is a therapeutic effect in brain tumour patients.

"If we have a better understanding of how microtubules and synapses are formed, the mechanisms behind this and the kind of messages sent between the cancer cells, then we can find out what impact this has on cancer development and treatment," says Hrvoje Miletic.


Story Source:

Materials provided by The University of Bergen. Note: Content may be edited for style and length.


Journal Reference:

  1. Varun Venkataramani, Dimitar Ivanov Tanev, Christopher Strahle, Alexander Studier-Fischer, Laura Fankhauser, Tobias Kessler, Christoph Körber, Markus Kardorff, Miriam Ratliff, Ruifan Xie, Heinz Horstmann, Mirko Messer, Sang Peter Paik, Johannes Knabbe, Felix Sahm, Felix T. Kurz, Azer Aylin Acikgöz, Frank Herrmannsdörfer, Amit Agarwal, Dwight E. Bergles, Anthony Chalmers, Hrvoje Miletic, Sevin Turcan, Christian Mawrin, Daniel Hänggi, Hai-Kun Liu, Wolfgang Wick, Frank Winkler, Thomas Kuner. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature, 2019; 573 (7775): 532 DOI: 10.1038/s41586-019-1564-x

Cite This Page:

The University of Bergen. "Cancer tumors form surprising connections with healthy brain cells." ScienceDaily. ScienceDaily, 27 September 2019. <www.sciencedaily.com/releases/2019/09/190927102458.htm>.
The University of Bergen. (2019, September 27). Cancer tumors form surprising connections with healthy brain cells. ScienceDaily. Retrieved December 21, 2024 from www.sciencedaily.com/releases/2019/09/190927102458.htm
The University of Bergen. "Cancer tumors form surprising connections with healthy brain cells." ScienceDaily. www.sciencedaily.com/releases/2019/09/190927102458.htm (accessed December 21, 2024).

Explore More

from ScienceDaily

RELATED STORIES